Hanall Biopharma Completes Disposal of 66,004 Treasury Shares
-
Hanall Biopharma submitted a report on disposal of treasury shares on May 6, 2026, disposing of 66,004 registered common shares.
-
The disposal resulted from stock option exercises, with the disposal price per share being the weighted average of exercise prices per tranche.
-
Post-disposal treasury share holdings are not separately stated in the report.
KOSPI Filing Information
-
Filing: Report On Results Of Disposal Of Treasury Shares
-
Company: Hanall Biopharma (009420)
-
Submission: Hanall Biopharma Co., Ltd.
-
Receipt: 05-06-2026